Medications in Bronchospasm and Asthma among the Critically Ill Patients: A Drug Utilization Study from Southern India
DOI:
https://doi.org/10.3126/nje.v1i2.5136Keywords:
Bronchospasm, Asthma, Southern India.Abstract
Objective: Critically ill patients are prone for altered reactivity of the airway and drug therapy has pivotal role in the management of bronchospasm. The objective of the study was to evaluate the prescribing patterns and adverse effects of therapeutic agents for bronchospasm and asthma in the medical ICU.
Methods: A prospective observational study was carried out among inpatients of the medical ICU receiving drugs for bronchospasm and asthma.
Results: 220 patients received drugs for bronchospasm and asthma. Male preponderance was noticed (60.5%). Salbutamol (R03AC02) 92.7% was the most common bronchodilator prescribed. Ipratropium plus salbutamol (R03AK04) 55.5% was most frequently used bronchodilator combination. All bronchodilators were administered by inhalational route (nebulization) except methylxanthines
Conclusion: Utilization patterns of drugs for bronchospasm and asthma were in concordance with treatment guidelines.
Key words: Bronchospasm; Asthma; Southern India
DOI: http://dx.doi.org/10.3126/nje.v1i2.5136
Nepal Journal of Epidemiology 2011;1 (2):57-59
Downloads
Downloads
How to Cite
Issue
Section
License
- Upon acceptance Copyright on any research article is transferred in full to the Confederation of Epidemiological Associations (CEA) and International Nepal Epidemiological Association (INEA). The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).
- Articles in the Nepal Journal of Epidemiology are Open Access articles published under the Creative Commons CC BY License (https://creativecommons.org/licenses/by/4.0/)
- This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.